alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with formaldehyde in 1 studies
| Studies (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Trials (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Recent Studies (post-2010) (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol) | Studies (formaldehyde) | Trials (formaldehyde) | Recent Studies (post-2010) (formaldehyde) |
|---|---|---|---|---|---|
| 90 | 1 | 2 | 22,546 | 243 | 5,887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beitz, AJ; Han, HJ; Kim, HW; Kim, KW; Kwon, YB; Lee, JH; Roh, DH; Yoon, SY | 1 |
1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and formaldehyde
| Article | Year |
|---|---|
Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.
Topics: Animals; Ethylenediamines; Formaldehyde; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain Measurement; Phosphorylation; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pyrimidines; Receptor, Serotonin, 5-HT1A; Receptors, N-Methyl-D-Aspartate; Receptors, sigma | 2006 |